Exner J H, Dahod S, Pochi P E
Arch Dermatol. 1983 Oct;119(10):808-11.
Three male patients with severe nodulocystic acne were treated with oral isotretinoin in a dosage of 0.5 to 1.0 mg/kg/day. A flare of their disease developed, characterized by an inflammatory, hemorrhagic, pyogenic, granuloma-like response of previously crusted acne lesions. This reaction occurred between the sixth and ninth weeks of treatment and was confined entirely to the chest and back. The severity of the reaction prompted the administration of oral prednisone and, in two cases, the discontinuation of isotretinoin therapy. In one patient, pyoderma gangrenosum developed on the thigh. The exact incidence of this pyogenic, granuloma-like reaction to isotretinoin is unknown, although we have seen it in three of 66 patients with nodulocystic acne treated with this drug. The cause of the reaction is unknown, but it may be due to the increased skin fragility and vascular proliferation known to be induced by isotretinoin.
三名重度结节囊肿性痤疮男性患者接受了口服异维甲酸治疗,剂量为0.5至1.0毫克/千克/天。他们的病情出现了一次爆发,其特征为先前结痂的痤疮皮损出现炎症性、出血性、化脓性、肉芽肿样反应。这种反应发生在治疗的第六至第九周,且完全局限于胸部和背部。反应的严重程度促使给予口服泼尼松治疗,在两例患者中,停止了异维甲酸治疗。在一名患者中,大腿上出现了坏疽性脓皮病。这种对异维甲酸的化脓性、肉芽肿样反应的确切发生率尚不清楚,尽管我们在66例接受该药物治疗的结节囊肿性痤疮患者中有3例观察到了这种情况。反应的原因尚不清楚,但可能是由于异维甲酸已知会导致皮肤脆性增加和血管增生。